Recent Developments in Health: Vaccines, Aid, and Cancer Treatments
Recent health updates include Pfizer/BioNTech's COVID vaccine showing better results in older adults, WHO urging the Taliban to lift restrictions on female aid workers in Afghanistan, and Eli Lilly's blood cancer drug Jaypirca meeting goals in a study. These developments highlight significant strides and challenges in health management.
In recent health news, Pfizer and BioNTech have announced that their updated COVID-19 vaccine demonstrates an improved immune response in adults over 65 and those aged 18 to 64 with underlying conditions, according to preliminary data from a late-stage trial. The companies reported a significant increase in LP.8.1-neutralizing antibodies following vaccination.
The World Health Organization has urged the Taliban government to remove restrictions on Afghan female aid workers. This request comes after a devastating earthquake in eastern Afghanistan, which has killed 2,200 people. The WHO emphasizes the critical need for female aid staff to provide necessary care to affected women.
Meanwhile, Eli Lilly's new blood cancer drug, Jaypirca, has shown promising results in extending patient survival without disease progression in a late-stage trial. This treatment, targeting chronic lymphocytic leukemia or small lymphocytic lymphoma, could potentially replace traditional chemoimmunotherapy in untreated patients.
(With inputs from agencies.)
ALSO READ
WHO's Call for Safeguarding CDC's Public Health Excellence
Noor Ahmad's Cricket Ascent: From IPL Stardom to Afghanistan's Hopes
Nawaz's Hat Trick Sparks Pakistan's Triumph Over Afghanistan
SC refuses to extend interim bail of convict Vikas Yadav, who is serving 25-year jail term in Nitish Katara murder case.
WHO Urges Taliban to Lift Restrictions on Female Aid Workers Amid Afghan Earthquake Crisis
Google News